Thermo Fisher Scientific insider to sell 30,000 shares

Thermo Fisher Scientific insider Michel Lagarde filed a notice to sell 30,000 shares of common stock under Rule 144.

Accepted by SEC EDGAR 12/02/2025 - 03:29 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Thermo Fisher Scientific insider Michel Lagarde filed a notice to sell 30,000 shares of common stock under Rule 144. The planned sale is through Fidelity Brokerage Services on the NYSE, with an aggregate market value of 17,457,611.41 based on the figures provided.

The shares relate to an option originally granted on 07/20/2016 and acquired on 12/02/2025, with payment made in cash. Lagarde also sold 4,638 common shares in a prior transaction on 11/13/2025, generating gross proceeds of 2,756,934.80.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Thermo Fisher Scientific (TMO) disclose in this Form 144?

The notice shows that Michel Lagarde plans to sell 30,000 shares of Thermo Fisher Scientific common stock under Rule 144 through Fidelity Brokerage Services on the NYSE.

How many Thermo Fisher Scientific (TMO) shares are proposed to be sold and on what exchange?

The filing indicates a proposed sale of 30,000 common shares of Thermo Fisher Scientific, to be traded on the NYSE.

What is the aggregate market value of the Thermo Fisher (TMO) shares in this planned Rule 144 sale?

The planned sale of 30,000 common shares has an aggregate market value of 17,457,611.41 based on the figures in the notice.

Who is the insider selling Thermo Fisher Scientific (TMO) shares and how were they acquired?

The seller is Michel Lagarde, and the 30,000 shares to be sold were acquired on 12/02/2025 from the issuer through an option granted on 07/20/2016, with payment made in cash.

Has the Thermo Fisher (TMO) insider sold other shares recently?

Yes. Over the past three months, 4,638 common shares were sold on 11/13/2025, generating gross proceeds of 2,756,934.80.

How many Thermo Fisher Scientific (TMO) shares are outstanding according to this notice?

The notice reports that 375,708,059 shares of Thermo Fisher Scientific common stock were outstanding, providing context for the planned 30,000-share sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001518973
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	THERMO FISHER SCIENTIFIC INC.
SEC File Number	001-08002
Address of Issuer	168 THIRD AVENUE WALTHAM MASSACHUSETTS 02451
Phone	7816221000
Name of Person for Whose Account the Securities are To Be Sold	Lagarde Michel
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	30000	17457611.41	375708059	12/02/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/02/2025	Option Granted - 07/20/2016	Issuer			30000	12/02/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Michel Lagarde 168 Third Avenue Waltham MA 02451	Common	11/13/2025	4638	2756934.80

144: Remarks and Signature

Remarks
Date of Notice	12/02/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gerardo Ibarra-Munoz, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Michel Lagarde
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)